Skip to content

Efficacy of transcranial magnetic stimulation in Parkinsons Disease

A randomized investigation of role of repetetive trans-cranial magnetic stimulation in parkinsons disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009064
Enrollment
53
Registered
2017-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Parkinsons Disease Health Condition 2: G20- Parkinsons disease

Interventions

Sponsors

All India Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of clinically definite PD, defined by UKPD brain bank clinical and diagnostic criteria. With presence of at least 1 out of 3 cardinal motor features of PD (resting tremor, rigidity, and postural impairment like bradykinesia); 2. PD patients of both gender with H&Y stage from 1 to 3. 3. PD patients between age 45 to 85 on stable medication for at least 30 days.

Exclusion criteria

Exclusion criteria: Subjects with any other neurological, psychiatric co-morbidities were excluded from the study. Hypertensives and diabetics were included only if they were stable on antihypertensives and oral hypoglycaemics for past 6 months from the time of enrollment. Also subjects with any ferromagnetic implants or dental fillings were excluded so were the subjects who were eligible for deep brain stimulation (DBS) and were scheduled to undergo surgery in next 6 months.

Design outcomes

Primary

MeasureTime frame
i. To compare the status of cortical plasticity between all the three treatment groups (M1, PM, SMA) using fMRI and FDG-PET. ii. To compare the clinical condition of the patients in the three treatment groups on the basis of UPDRS, H & Y scale, PDQ-39, HAM-A, HAM-D, HADS and CGI. iii. To compare the motor performance of the patient using Purdue peg-board test, and Timed motor tests. Timepoint: Baseline 0 day Post Sham at 4th week Post Real at 8th week [Baseline:-After recruitment Post-Sham:-After 4 sessions of Sham TMS Post-Real:- After 4 sessions of Real TMS.]

Secondary

MeasureTime frame
1.To compare the clinical condition of the patients in the three treatment groups on the basis of UPDRS, H & Y scale, PDQ-39, HAM-A, HAM-D, and CGI. 2.To compare the motor performance of the patient using Purdue peg-board test, and Timed motor tests. Timepoint: Baseline 0 day Post Sham at 4th week Post Real at 8th week [Baseline:-After recruitment Post-Sham:-After 4 sessions of Sham TMS Post-Real:- After 4 sessions of Real TMS.]

Countries

India

Contacts

Public ContactPriyanka Bhat

Dept. Of Neurology, AIIMS, Delhi

bhatpriyanka84@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026